La dernière actualité médicale WillebrandXPERT Consultez la version en ligne Chère consœur, cher confrère, Retrouvez ci-après les dernières publications scientifiques issues de revues à comité de lecture dans votre domaine d'expertise. Publications du  Jeudi 21 mai 2026 Clinical, Obstetric-Gynaecological and HRQoL Data of Female VWD Patients in the WIL-QoL Study Haemophilia. Volume 32(1). Von Willebrand disease (VWD) is one of the most common hereditary disorders of primary haemostasis. Females with VWD often report heavy menstrual bleeding (HMB) that can significantly impact health-related... En savoir plus |  Version PDF  |  Imprimer l'abstract Postpartum well-being in hemophilia carriers and women with von Willebrand disease: insights from patient-reported outcome measures Research and Practice in Thrombosis and Haemostasis 2026; 10(3): 103418 Hemophilia carriers (HCs) and women with von Willebrand disease (VWD) receive specialized obstetric care because of a higher chance for postpartum bleeding and potential bleeding in the neonates. It is... En savoir plus |  Version PDF  |  Imprimer l'abstract Validation approach of an LC-MS/MS assay for ADA detection, applied to a Von Willebrand factor-targeted biotherapeutic Bioanalysis 2026; aop:10.1080/17576180.2026.2679064 The efficiency of ligand binding assay (LBA)-based immunogenicity assessment can be compromised by the presence of high concentrations of soluble pharmacological target. This is particularly challenging... En savoir plus |  Version PDF  |  Imprimer l'abstract Accueil  |  Actualités  |  Archives Informer un confrère | Modifier votre profil | Supprimer mes données | Sources et critères Copyright 2026 © GNM Healthcare Group Companies USA, Inc.